ClinicalTrialsFinder
RecruitingNCT06496555

Evaluation of U-AKIpredTM for Predicting AKI in Critically Ill Patients Within 12 Hours: a Multicenter Prospective Cohort Study

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

2,100 participants

Start Date

Jun 1, 2024

Study Type

OBSERVATIONAL

Conditions

External Effectiveness Validation of Model

Summary

The goal of our study is to evaluate U-AKIpredTM for predicting AKI in critically ill patients within 12 h by the multicenter prospective cohorts. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO) criteria. We designed five aspects including the overall fitting effecience evaluation, calibration curve, quantifying calibration performance, quantifying discrimination performance, quantifying clinical utility to evaluate the external validation model.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • critically ill patients who stayed in ICU for over 24 h;
  • patients older than 18 years of age.

Exclusion Criteria6

  • patients who admitted in ICU had been diagnosed acute kidney injury;
  • patients who admitted in ICU had been diagnosed acute kidney disease;
  • patients who admitted in ICU had been diagnosed chronic kidney disease;
  • patients who admitted in ICU had performed kidney dialysis;
  • patients who admitted in ICU had performed kidney transplantation;
  • Pregnant women.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06496555